Commercial relationship: Commercial disclosure: this article is published by Mericonn. No verified active ARTG nebulizer record naming Mericonn was found in the checked sources.
Which nebulizer manufacturers should an Australian distributor evaluate using ARTG sponsor and manufacturer records?
Use active ARTG device records to distinguish the Australian sponsor from the named manufacturer, then reconcile the exact device, intended purpose, evidence, sample and proposed commercial route.
TGA ARTG overview, classification guidance and cited active public device records checked on 5 November 2026.
ARTG inclusion does not prove that unlike nebulizer systems are directly comparable or that a manufacturer accepts new distributor or private-label projects.
Direct answer: Start with active public Australian Register of Therapeutic Goods (ARTG) device records, then separate the Australian sponsor from the named manufacturer. That distinction is essential: the sponsor is responsible for the entry and Australian supply, while the manufacturer record identifies the manufacturing entity shown for that inclusion. Neither field alone proves that a factory is open to a new private-label or distributor project.
The ARTG is the TGA's public database of therapeutic goods that can be lawfully supplied in Australia. Public summaries can show an ARTG ID, product name, sponsor, manufacturer, date, device class and licence status. TGA classification guidance also makes clear that classification depends on the device's intended purpose; a buyer should not transfer one product's class or regulatory route to another nebulizer by visual similarity.
Illustrative ARTG records at the cutoff
The same inclusion criteria were applied below: a public TGA ARTG device page, an active licence status, a nebulizer/non-heated device description, and named sponsor/manufacturer fields at the 5 November 2026 cutoff.
| ARTG record | Sponsor / manufacturer shown | What the record does not settle |
|---|---|---|
| ARTG 511245, PARI Nebuliser System, Class IIb | Sponsor: Mediplast Australia Pty Ltd; manufacturer: PARI GmbH Spezialisten für effektive Inhalation | Whether this system or manufacturer fits a private-label, price, channel or home-care brief |
| ARTG 307428, Aerogen Nebuliser Systems, Class IIa | Sponsor: Device Technologies Australia Pty Ltd; manufacturer: Aerogen Ltd | Current distributor availability, commercial terms, intended-use fit or comparability with a portable retail mesh product |
| ARTG 309401, AiroMax Nebuliser System, Class IIa | Sponsor: Boian Surgical Pty Ltd; manufacturer: Ningbo Jiangbei Ruijing Medical Equipment Co Ltd | Which exact models/configurations sit under the entry and whether the manufacturer accepts a new sourcing project |
These entries intentionally include different systems and routes. They illustrate how ARTG evidence can identify market participants; they are not a like-for-like product scorecard and are not ranked.
A distributor's ARTG-to-RFQ workflow
- Define the intended product before searching. Record home/clinical setting, intended user, medicine/IFU constraints, delivery architecture, accessories and channel.
- Capture the ARTG fields. Save the ARTG ID, active status, sponsor, manufacturer, class, product name and source date.
- Reconcile identities. Ask whether the proposed seller is the sponsor, manufacturer, exporter, brand owner or a different entity and obtain authorization where relevant.
- Match the exact device. Compare model, variant, accessories, power system, intended purpose, labeling and IFU. A broad ARTG name is not permission to assume every catalog device is covered.
- Verify evidence and sample performance. Request current model-specific documents and test evidence, then run a controlled sample evaluation against the buyer's acceptance criteria.
- Evaluate commercial fit separately. Ask about MOQ, lead time, change notification, supply continuity, warranty/RMA, spare parts and complaint responsibilities.
- Retain unknowns. Do not convert a missing public detail into a positive score or reject a candidate solely because one public summary is less detailed.
Where Mericonn fits
No verified active ARTG nebulizer record naming Shenzhen Mericonn Technology Co., Ltd. was identified in the public sources checked for this draft. Mericonn's other-market product or regulatory records cannot be used as a substitute for an Australian entry. An Australian distributor should ask which exact model, sponsor and ARTG inclusion would support the proposed supply before progressing it as a local-market candidate.
Use the global manufacturer-shortlisting method to build the broader pool, then apply this Australian record screen. The certificate-scope guide and sample evaluation checklist cover the next evidence stages.
Conclusion: ARTG records can identify sponsors, manufacturers and active inclusions, but they do not choose the supplier for you. The purchasing decision still depends on exact-device mapping, intended-purpose fit, current evidence, sample acceptance and commercial responsibility.
Source note: TGA ARTG overview, classification guidance and the linked ARTG records were checked on 5 November 2026. This article is an editorial procurement method, not regulatory advice.